Impact of pre-transplant dialysis modality on post-transplant diabetes mellitus after kidney transplantation

Clinical Transplantation

Volumn 25, Issue 5, 2011, Pages 794-799

  Courivaud, Cécile ^a   Ladrière, Marc ^b   Toupance, Olivier ^c   Caillard, Sophie ^c   de Ligny, Bruno Hurault ^d   Ryckelynck, Jean Philippe ^d   Moulin, Bruno ^c   Rieu, Philippe ^c   Frimat, Luc ^b   Chalopin, Jean Marc ^a   Chauvé, Sylvie ^c   Kazory, Amir ^e   Ducloux, Didier ^a  

^a HÔPITAL SAINT JACQUES   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

^c Department of Nephrology Dialysis and Renal Transplantation ^*  (France)

^d CHU Clemenceau   (France)

^e UNIVERSITY OF FLORIDA   (United States)

Author keywords

Hemodialysis; Kidney transplantation; Peritoneal dialysis; Post transplant diabetes mellitus

Indexed keywords

CYCLOSPORIN A; GANCICLOVIR; INSULIN; ORAL ANTIDIABETIC AGENT; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BODY MASS; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; DIALYSIS; DISEASE ASSOCIATION; FEMALE; GRAFT RECIPIENT; HEMODIALYSIS; HEPATITIS C; HUMAN; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; POSTTRANSPLANT DIABETES MELLITUS; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 80054099912     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2010.01367.x     Document Type: Article

References (27)

1. Ostenson CG. The pathophysiology of type 2 diabetes mellitus: an overview. Acta Physiol Scand 2001: 171: 247.
2. Kasiske BL. Epidemiology of cardiovascular disease after renal transplantation. Transplantation 2001: 72(Suppl 6): S5.
3. Renavur VK, Jardine AG, Kingsmore DB, Jacques BC, Hamilton DH, Jindal RM. Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation. Clin Transplant 2001: 15: 89.
4. Hariharan S, Johnson CP, Bresnahan BA, Taranto Se, McIntosh MJ, Stblein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000: 342: 605.
5. Pascual M, Theruvath T, Kawai T, Tolkoff-Rubin N, Cosimi AB. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002: 346: 580.
6. Davidson J, Wilkinson A, Dantal J et al. New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 Feb. 2003. Transplantation 2003: 75(Suppl 10): S3.
7. Ducloux D, Kazory A, Simula-Faivre D, Chalopin JM. One-year post-transplant weight gain is a risk factor for graft loss. Am J Transplant 2005: 5: 2922.
8. Yoshihara F, Kojima M, Hosoda H, Nakazato M, Kangawa K. Ghrelin: a novel peptide for growth hormone release and feeding regulation. Curr Opin Clin Nutr Metab Care 2002: 5: 391.
9. Yoshimoto A, Mori K, Sugawara A et al. Plasma ghrelin and desacyl ghrelin concentrations in renal failure. J Am Soc Nephrol 2002: 13: 2748.
10. Rodriguez Ayala E, Pecoits-Filho R, Heimburger O, Lindholm B, Nordfors L, Stenvinkel P. Associations between plasma ghrelin levels and body composition in end-stage renal disease: a longitudinal study. Nephrol Dial Transplant 2004: 19: 421.
11. Bamoulid J, Courivaud C, Deschamps M et al. IL-6 promoter polymorphism -174 is associated with new-onset diabetes after transplantation. J Am Soc Nephrol 2006: 17: 2333.
12. McKenna RM, Macdonald C, Bernstein KN, Rush DN. Increased production of tumor necrosis factor activity by hemodialysis but not peritoneal dialysis patients. Nephron 1994: 67: 190.
13. Wong CK, Szeto CC, Chan MH, Leung CB, Li PK, Lam CW. Elevation of pro-inflammatory cytokines, C-reactive protein and cardiac troponin T in chronic renal failure patients on dialysis. Immunol Invest 2007: 36: 47.
14. Ducloux D, Kazory A, Chalopin JM. Posttransplant diabetes mellitus and atherosclerotic events in renal transplant recipients: a prospective study. Transplantation 2005: 79: 438.
15. Joss N, Staatz CE, Thomson AH, Jardine AG. Predictors of new onset diabetes after renal transplantation. Clin Transplant 2007: 21: 136.
16. Baltar J, Ortega T, Ortega F et al. Posttransplantation diabetes mellitus: prevalence and risk factors. Transplant Proc 2005: 37: 3817.
17. Mayer AD, Dmitrewski J, Squifflet JP et al. Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group. Transplantation 1997: 64: 436.
18. Marin M, Renoult E, Bondor CI, Kessler M. Factors influencing the onset of diabetes mellitus after kidney transplantation: a single French centre experience. Transplant Proc 2005: 37: 1851.
19. Ducloux D, Motte G, Vautrin P, Bresson-Vautrin C, Rebibou JM, Chalopin JM. Polycystic kidney disease as a risk factor for post-transplant diabetes mellitus. Nephrol Dial Transplant 1999: 14: 1244.
20. Montori VM, Basu A, Erwin PJ, Velosa JA, Gabriel SE, Kudva YC. Posttransplantation diabetes: a systematic review of the literature. Diabetes Care 2002: 25: 583.
21. Cosio FG, Pesavento TE, Osei K, Henry ML, Ferguson RM. Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int 2001: 59: 732.
22. Boudreaux JP, McHugh L, Canafax DM et al. The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients. Transplantation 1987: 44: 376.
23. Jawad F, Rizvi SA. Posttransplant diabetes mellitus in live-related renal transplantation. Transplant Proc 2000: 32: 1888.
24. Hjelmesaeth J, Hartmann A, Kofstad J et al. Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. Transplantation 1997: 64: 979.
25. Al-Uzri A, Stablein DM, A Cohn R. Posttransplant diabetes mellitus in pediatric renal transplant recipients: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Transplantation 2001: 72: 1020.
26. Webster AC, Woodroffe RC, Taylor RS, Chapman JR, Craig JC. Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data. BMJ 2005: 331: 810.
27. Vincenti F, Friman S, Scheuermann E et al. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant 2007: 7: 1506.